Login / Signup

Characterization of Pediatric Reports in the US Food and Drug Administration Adverse Event Reporting System from 2010-2020: A Cross-Sectional Study.

Michael T PhanCarmen ChengVivian DangEileen WuMonica A Muñoz
Published in: Therapeutic innovation & regulatory science (2023)
Pediatric ICSRs represent a minority of FAERS reports but have distinctly different attributes relative to adult ICSRs. Reporting trends also vary within pediatric subgroups, which highlights the need for unique considerations for pediatric safety surveillance.
Keyphrases
  • adverse drug
  • childhood cancer
  • drug administration
  • emergency department
  • public health
  • risk assessment
  • drug induced